CRSP SBC to Revenue

Crispr Therapeutics Ag · SBC to Revenue

CRSP logo

CRSP SBC to Revenue

Current (TTM)510.16%
CRSP SBC/Revenue (0.00% → 510.16%)
High-resolution chart · PNG

CRSP sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
2,065.4986%
247.3343%
21.8995%
22,464.9083%
11.2137%
9,181.9193%
15.2136%
1,119.8784%
46.0351%
209.9923%
1,491.498%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.